Trials · 2019 · 54 citations · 18 references
PharmacySurgeryClinical Trial RegulationEvidence-based PracticeHealth Services ResearchClinical Trial Approval ProcessesClinical Trial Protocol ReviewClinical TrialsSponsor ResponsibilitiesStudy DesignTrial MonitoringAdvisory RolesTeamwork In Surgery
BACKGROUND AND AIMS: Historically, patient and public involvement (PPI) in the design and conduct of surgical trials has been absent or minimal, but it is now routinely recommended and even required by some research funders. We aimed to identify and describe current PPI practice in surgical trials in the United Kingdom, and to explore the views and experiences of surgical trial staff and patient or public contributors in relation to these practices. This was part of a larger study to inform development of a robust PPI intervention aimed at improving recruitment and retention in surgical trials. METHODS: Our study had two stages: 1) an online survey to identify current PPI practice in active UK-led, adult surgical trials; and 2) focus groups and interviews with key stakeholders (surgical trial investigators, administrators, and patient or public contributors) to explore their views and experiences of PPI. RESULTS: Of 129 eligible surgical trial teams identified, 71 (55%) took part in the survey. In addition, 54 stakeholders subsequently took part in focus groups or interviews. Sixty-five (92%) survey respondents reported some kind of PPI, most commonly at the design and dissemination stages and in oversight or advisory roles. The single most common PPI activity was developing participant information sheets (72%). Participants reported mixed practice and views on a variety of issues including the involvement of patients versus lay members of the public, recruitment methods, use of role descriptions and payment for the time of PPI contributors. They suggested some solutions, including the use of written role descriptions and databases of potential PPI contributors to aid recruitment. CONCLUSIONS: UK surgical trials involve patients and members of the public in a variety of different ways, most commonly at the beginning and end of the trial lifecycle and in oversight or advisory roles. These are not without challenges and there remain uncertainties about who best to involve, why, and how. Future research should aim to address these issues.
18
National Institute for Health Research
Roger G. Evans · Nursing Standard · 2014 · 1.4K citations
Public Affairs, Health Policy, Health Services Administration +4
Heather Bagley, Hannah Short, Nicola Harman et al. · Research Involvement and Engagement · 2016 · 210 citations · Full text
Public Health, Public Health Practice, Community Engagement +9
Joanna Crocker, Anne‐Marie Boylan, Jennifer Bostock et al. · Health Expectations · 2016 · 199 citations · Full text